SODIUM IODIDE I 131 (MALLINCKRODT NUCLEAR MEDICINE LLC)


Welcome to the PulseAid listing for the SODIUM IODIDE I 131 drug offered from MALLINCKRODT NUCLEAR MEDICINE LLC. This Radioactive Therapeutic Agent [EPC],Radiopharmaceutical Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: MALLINCKRODT NUCLEAR MEDICINE LLC
NON-PROPRIETARY NAME: sodium iodide i 131
SUBSTANCE NAME: SODIUM IODIDE I-131
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Radioactive Therapeutic Agent [EPC],Radiopharmaceutical Activity [MoA]
ROUTE: ORAL
DOSAGE FORM: CAPSULE, GELATIN COATED
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2015-10-27
END MARKETING DATE: 0000-00-00


SODIUM IODIDE I 131 HUMAN PRESCRIPTION DRUG Details:

Item DescriptionSODIUM IODIDE I 131 from MALLINCKRODT NUCLEAR MEDICINE LLC
LABELER NAME: MALLINCKRODT NUCLEAR MEDICINE LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 1(mCi/mL)
START MARKETING DATE: 2015-10-27
END MARKETING DATE: 0000-00-00
PRODUCT ID: 69945-452_63bb1be3-a538-4ac8-8908-880231980efb
PRODUCT NDC: 69945-452
APPLICATION NUMBER: NDA016517

Other SODIUM IODIDE I-131 Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
AnazaoHealth CorporationI 131 Mini
International Isotopes IncSodium Iodide I-131
Jubilant DraxImage Inc.Sodium Iodide I 131 Diagnostic
MALLINCKRODT NUCLEAR MEDICINE LLCSodium Iodide I-131